MIM
FLACW

Monashee Investment Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Monashee Investment Management’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-299,999
Closed -$2.51M – 239
2021
Q3 		$2.51M Buy
299,999
+250,000
+500% +$224K 0.46% 48
2021
Q2 		$55K Hold
49,999
– – 0.01% 365
2021
Q1 		$45K Buy
+49,999
New +$84.6K 0.01% 345

Other funds holding FLACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32M AUM 108.13% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Monashee Investment Management's FLACW Position: Q4 2021 in Review

Monashee Investment Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2021, closing a stake of 299,999 shares — an estimated $2.51M sold.

Monashee Investment Management first reported a position in FLACW in Q1 2021 and held it in 3 quarters. The position peaked at $2.51M in Q3 2021. 29 funds tracked by Wall St. Rank hold FLACW as of Q4 2021.

  • Monashee Investment Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2021 after selling out during the quarter.
  • Monashee Investment Management sold 299,999 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2021, an estimated $2.51M.
  • Monashee Investment Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 3 quarters.
  • Monashee Investment Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $2.51M in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.